MRI
RadiationThe study-specified MRI scan includes RF- and gradient-intensive sequences designed to test the ImageReady System in the MR environment
Other names: MR Scan
NCT Number: NCT01781078
The objective of the SAMURAI Clinical Study is to collect data to confirm the safety, performance and effectiveness of the ImageReady System for use in the Magnetic Resonance Imaging (MRI) environment when used in accordance with the Conditions of Use included in the Boston Scientific MRI Technical Guide
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
St Vincent's Hospital, Melbourne, Victoria, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study-specified MRI scan includes RF- and gradient-intensive sequences designed to test the ImageReady System in the MR environment
Other names: MR Scan
Pacemaker and lead(s) implant
Other names: Single chamber pacemaker implant, Dual chamber pacemaker implant, Pace/ Sense pacemaker lead implant
Time frame: MRI Visit + 1 Month
The primary safety endpoint for SAMURAI will be assessed for all subjects randomized to the MRI Group who undergo any portion of the MRI scan sequences. Safety will be confirmed by evaluating the MRI scan-related Complication-free rate (CFR) between the MR Scan and the MRI Visit + 1 Month Visit.
Time frame: MRI + 1 Month Visit
The MRI scan can result in damage to cardiac tissue surrounding lead electrodes due to RF field-induced heating, which in turn may cause elevated pacing thresholds. Primary Effectiveness Endpoint 1 will evaluate any chronic effects from lead heating that will be seen through increased pacing threshold at the MRI Visit + 1 Month follow-up.
Subjects with an increase in pacing thresholds s 0.5V (at 0.5 ms) from pre-MR Scan/Control Group visit to MRI/Control visit + 1 Month follow-up were considered a success. A success rate was calculated for both the MRI and the Control Groups.
Time frame: MRI + 1 Month Visit
The MRI scan can result in damage to cardiac tissue surrounding lead electrodes due to Radiofrequency (RF) field-induced heating. Primary Effectiveness Endpoint 2 will evaluate any chronic effects from lead heating that will be seen through decreased sensed amplitude at the MRI Visit + 1 Month follow-up. Data were analyzed separately by chamber, Right Atrium (RA) and Right Ventricle (RV), for this endpoint.
Time frame: 3 months post implant
Overall safety of the ImageReady System will be confirmed by evaluating system-related complications that occur from system implant through 3 months post implant for all subjects who underwent an implant procedure and and reached 91 days of follow-up.
Boston Scientific Corporation
Industry
Acronym: SAMURAI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06540079
Arrhythmia, Sinus, Arrhythmias, Cardiac
Phoenix, Arizona, United States
View Trial DetailsNCT05887323
Arrhythmia, Sinus, Arrhythmias, Cardiac
Jonesboro, Arkansas, United States
View Trial DetailsNCT04632641
Arrhythmia, Sinus, Arrhythmias, Cardiac
Milwaukee, Wisconsin, United States
View Trial DetailsNCT03719040
Arrhythmia, Sinus, Arrhythmias, Cardiac
Huntsville, Alabama, United States
View Trial Details